title: Structural modifications of the ACTH-(4-9) analog ORG 2766 yields peptides with high biological activity.
abstract: The behavioral effects of two peptides (HOE 427) and ORG 31433) related to the ACTH-(4-9) analog ORG 2766 were investigated in Wistar rats in a number of tests in which Org 2766 is active. Subcutaneous administration of HOE 427 in a dose of 0.5 ng/kg or ORG 31433 in doses of 0.5-5.0 ng/kg facilitated passive avoidance behavior whereas these peptides attenuated the avoidance response in doses of 25 ng/kg and 250 ng/kg respectively. ORG 31433 (0.1 - 1.0 microgram/kg) decreased motor activity of group housed rats tested under low light conditions. Furthermore subcutaneous (1.0- 10.0 ng/kg) or oral (10 microgram/kg) administration of ORG 31433 accelerated functional recovery from 6-hydroxydopamine (6-OHDA)-induced lesions in the nucleus accumbens which cause motor hypoactivity. The experiments show that as compared to ORG 2766 the peptides HOE 427 and ORG 31433 induce qualitatively similar responses but are approximately 10 to 100 times more potent. These data may imply that substitution of the C-terminal COOH group of ORG 2766 yields neuropeptides with increased potency.
authors.affiliation: Rudolf Magnus Institute, Faculty of Medicine, University of Utrecht, The Netherlands.
authors.forename: G
authors.initials: G
authors.lastname: Wolterink
authors.forename: J M
authors.initials: JM
authors.lastname: van Ree
authors.forename: J W
authors.initials: JW
authors.lastname: van Nispen
authors.forename: D
authors.initials: D
authors.lastname: de Wied
mesh_terms: D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006892:Hydroxydopamines / Q000633:toxicity; D007279:Injections, Subcutaneous; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D009714:Nucleus Accumbens / Q000187:drug effects; D016627:Oxidopamine; D010446:Peptide Fragments / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D000927:Anticonvulsants; D006892:Hydroxydopamines; D010446:Peptide Fragments; C067289:Org 31433; C013765:Org 2766; D016627:Oxidopamine; D000324:Adrenocorticotropic Hormone; C057139:ebiratide